- Home
- ISD vs LAB Comparison
ISD vs LAB Comparison
Compare ISD & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISD
- LAB
- Stock Information
- Founded
- ISD 2012
- LAB 1999
- Country
- ISD United States
- LAB United States
- Employees
- ISD N/A
- LAB N/A
- Industry
- ISD Trusts Except Educational Religious and Charitable
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- ISD Finance
- LAB Industrials
- Exchange
- ISD Nasdaq
- LAB Nasdaq
- Market Cap
- ISD 472.3M
- LAB 505.7M
- IPO Year
- ISD N/A
- LAB 2011
- Fundamental
- Price
- ISD $14.31
- LAB $1.33
- Analyst Decision
- ISD
- LAB Buy
- Analyst Count
- ISD 0
- LAB 2
- Target Price
- ISD N/A
- LAB $2.50
- AVG Volume (30 Days)
- ISD 127.1K
- LAB 1.5M
- Earning Date
- ISD 01-01-0001
- LAB 08-11-2025
- Dividend Yield
- ISD 9.69%
- LAB N/A
- EPS Growth
- ISD N/A
- LAB N/A
- EPS
- ISD N/A
- LAB N/A
- Revenue
- ISD N/A
- LAB $169,687,000.00
- Revenue This Year
- ISD N/A
- LAB N/A
- Revenue Next Year
- ISD N/A
- LAB $12.18
- P/E Ratio
- ISD N/A
- LAB N/A
- Revenue Growth
- ISD N/A
- LAB 33.86
- 52 Week Low
- ISD $10.98
- LAB $0.92
- 52 Week High
- ISD $13.17
- LAB $2.34
- Technical
- Relative Strength Index (RSI)
- ISD 63.17
- LAB 52.62
- Support Level
- ISD $14.01
- LAB $1.36
- Resistance Level
- ISD $14.14
- LAB $1.45
- Average True Range (ATR)
- ISD 0.10
- LAB 0.08
- MACD
- ISD 0.01
- LAB -0.00
- Stochastic Oscillator
- ISD 80.26
- LAB 37.14
About ISD PGIM High Yield Bond Fund Inc.
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The Fund's investment objective is to provide a high level of current income. It invests at least 80% of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.